Literature DB >> 16708216

Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis.

Tijmen Korteweg1, Bernard M J Uitdehaag, Dirk L Knol, Robin H M Smithuis, Paul R Algra, Cees de Vries, Peter A Poppe, Jan-Hein T M van Waesberghe, Elisabeth Bergers, Geert J Lycklama à Nijeholt, Chris H Polman, Frederik Barkhof.   

Abstract

We assessed the interobserver agreement on the radiological part of the International Panel (IP) criteria for the diagnosis of multiple sclerosis (MS), comprising the assessment of dissemination in space (DIS) and time (DIT) based exclusively on MRI. Four radiologists trained and four radiologists naive in the application of the IP criteria scored the fulfillment for DIS (i.e., > or =3 periventricular, > or =1 infratentorial, > or =1 juxtacortical, > or = 1 enhancing lesion or a total of > or =9 T2-weighted lesions) and DIT (presence of new or enhancing lesions at follow-up) in baseline and two follow-up scans from 20 patients suspected for having MS. The IP-trained radiologists agreed at least moderately on all assessments (kappa>0.40), whereas the IP-naive radiologists showed fair agreement (kappa<0.40) on five of 16 assessments. In the final conclusion on DIS and DIT, the IP-trained radiologists agreed substantially on both items (kappa=0.62 and kappa=0.60, respectively) compared with a fair agreement on DIS (kappa=0.29) and moderate agreement on DIT (kappa=0.52) among the IP-naive radiologists. Given the poor interobserver agreement among IP-naive observers, the new IP criteria for MS require additional training and should perhaps be simplified.

Entities:  

Mesh:

Year:  2006        PMID: 16708216     DOI: 10.1007/s00330-006-0303-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group.

Authors: 
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

3.  New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Authors:  M Tintoré; A Rovira; J Río; C Nos; E Grivé; J Sastre-Garriga; I Pericot; E Sánchez; M Comabella; X Montalban
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

4.  Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis.

Authors:  V Zipoli; E Portaccio; G Siracusa; G Pracucci; S Sorbi; M P Amato
Journal:  Mult Scler       Date:  2003-10       Impact factor: 6.312

5.  Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis.

Authors:  M Filippi; M L Gawne-Cain; C Gasperini; J H vanWaesberghe; J Grimaud; F Barkhof; M P Sormani; D H Miller
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

6.  Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis.

Authors:  F Barkhof; M Filippi; J H van Waesberghe; A Campi; D H Miller; H J Adèr
Journal:  Neuroradiology       Date:  1999-05       Impact factor: 2.804

7.  Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility.

Authors:  P D Molyneux; D H Miller; M Filippi; T A Yousry; E W Radü; H J Adèr; F Barkhof
Journal:  Neuroradiology       Date:  1999-12       Impact factor: 2.804

8.  Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Catherine M Dalton; Peter A Brex; Katherine A Miszkiel; Simon J Hickman; David G MacManus; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Ann Neurol       Date:  2002-07       Impact factor: 10.422

9.  New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes.

Authors:  Catherine M Dalton; Peter A Brex; Katherine A Miszkiel; Kryshani Fernando; David G MacManus; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  8 in total

Review 1.  The radiologically isolated syndrome: look (again) before you treat.

Authors:  Rebecca Spain; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

2.  Reproducibility of Lesion Count in Various Subregions on MRI Scans in Multiple Sclerosis.

Authors:  Bence Bozsik; Eszter Tóth; Ilona Polyák; Fanni Kerekes; Nikoletta Szabó; Krisztina Bencsik; Péter Klivényi; Zsigmond Tamás Kincses
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

3.  High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.

Authors:  Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Hans H Schild; Frank Träber
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

4.  Conventional and synthetic MRI in multiple sclerosis: a comparative study.

Authors:  Wolfgang Krauss; Martin Gunnarsson; Margareta Nilsson; Per Thunberg
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

5.  Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion.

Authors:  Hagen H Kitzler; Hannes Wahl; Judith C Eisele; Matthias Kuhn; Henning Schmitz-Peiffer; Simone Kern; Brian K Rutt; Sean C L Deoni; Tjalf Ziemssen; Jennifer Linn
Journal:  Neuroimage Clin       Date:  2018-05-31       Impact factor: 4.881

6.  Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern India.

Authors:  T K Banerjee; M Saha; E Ghosh; A Hazra; A Das; D Choudhury; S Ojha; A Haldar; A Mukherjee; S S Nandi; A Ghosh; A Mukherjee; A Chatterjee; A Datta; S Purakayastha
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-05-13

7.  Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.

Authors:  Marloes Hj Hagens; Jessica Burggraaff; Iris D Kilsdonk; Serena Ruggieri; Sara Collorone; Rosa Cortese; Niamh Cawley; Emilia Sbardella; Michaela Andelova; Michael Amann; Johanna M Lieb; Patrizia Pantano; Birgit I Lissenberg-Witte; Joep Killestein; Celia Oreja-Guevara; Jens Wuerfel; Olga Ciccarelli; Claudio Gasperini; Carsten Lukas; Alex Rovira; Frederik Barkhof; Mike P Wattjes
Journal:  Mult Scler       Date:  2018-01-12       Impact factor: 6.312

8.  A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.

Authors:  T Korteweg; M Tintore; B M J Uitdehaag; D L Knol; H Vrenken; A Rovira; J Frederiksen; D H Miller; K Fernando; M Filippi; F Agosta; M A Rocca; F Fazekas; C Enzinger; A Parry; C H Polman; X Montalban; F Barkhof
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.